Emisphere Technologies, Inc. (NASDAQ: EMIS) today announced data from a clinical study designed to assess the effect of oral administration ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE